Mechanism of Action Comparison# Retatrutide# Retatrutide (LY3437943) is a 39-amino acid peptide that simultaneously activates three metabolically important receptors: GLP-1 receptor : Enhances glucose-dependent insulin secretion, suppresses glucagon release, slows gastric emptying, and promotes central satiety signaling GIP receptor : Potentiates insulin secretion, may improve beta-cell function, and contributes to adipose tissue metabolism Glucagon receptor : Increases hepatic glucose output acutely but chronically promotes hepatic fat oxidation, thermogenesis, and energy expenditure The glucagon receptor component distinguishes retatrutide from all other approved or late-stage metabolic peptides
Jaundice is a sign that something may be wrong with the liver or bile system
Patients on immunosuppressive medications (5-ASAs, azathioprine, biologics like infliximab) can generally use GLP-1s concurrently, though each combination warrants provider review
Huang PJ, Huang YC, Su MF, et al
Clinical Response Results from both studies demonstrated statistically significant reduction of the risk of treatment failure in subjects treated with HUMIRA versus subjects receiving placebo
This is called "overfill" or "dead volume" and most manufacturers account for it by adding slightly more liquid than the labeled amount